These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38387405)

  • 1. Authors' reply to Letter regarding "Probing Long COVID through a Proteomic Lens: a Comprehensive Two-Year Longitudinal Cohort Study of Hospitalised Survivor".
    Gu X; Wong CCL; Cao B
    EBioMedicine; 2024 Mar; 101():105029. PubMed ID: 38387405
    [No Abstract]   [Full Text] [Related]  

  • 2. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.
    Gu X; Wang S; Zhang W; Li C; Guo L; Wang Z; Li H; Zhang H; Zhou Y; Liang W; Li H; Liu Y; Wang Y; Huang L; Dong T; Zhang D; Wong CCL; Cao B
    EBioMedicine; 2023 Dec; 98():104851. PubMed ID: 37924708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to commentary 'long COVID-19/post-COVID condition in children: do we all speak the same language?
    Trapani G; Verlato G; Bertino E; Maiocco G; Vesentini R; Spadavecchia A; Dessì A; Fanos V
    Ital J Pediatr; 2022 Dec; 48(1):200. PubMed ID: 36536440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID or long-COVID? That is the question. Authors' reply.
    Lippi G; Sanchis-Gomar F; Henry BM
    Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 37219465
    [No Abstract]   [Full Text] [Related]  

  • 5. Concerns regarding a suggested long COVID paradigm - Authors' reply.
    Saunders C; Sperling S; Bendstrup E
    Lancet Respir Med; 2023 Apr; 11(4):e36-e37. PubMed ID: 36997265
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study.
    Borgonovo F; Lovaglio PG; Mariani C; Berta P; Cossu MV; Rizzardini G; Vittadini G; Capetti AF
    BMJ Open; 2024 Feb; 14(2):e075185. PubMed ID: 38320835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of COVID-19 at 1-year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study.
    O'Kelly B; Vidal L; Avramovic G; Broughan J; Connolly SP; Cotter AG; Cullen W; Glaspy S; McHugh T; Woo J; Lambert JS
    Int J Infect Dis; 2022 May; 118():236-243. PubMed ID: 35301101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glimpse into long COVID and symptoms - Authors' reply.
    Huang L; Gu X; Zhang H; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):e82. PubMed ID: 35697052
    [No Abstract]   [Full Text] [Related]  

  • 9. Long COVID in children - Authors' reply.
    Molteni E; Bhopal SS; Hughes RC; Absoud M; Duncan EL;
    Lancet Child Adolesc Health; 2022 Jan; 6(1):e3. PubMed ID: 34921808
    [No Abstract]   [Full Text] [Related]  

  • 10. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study.
    Rivera-Izquierdo M; Láinez-Ramos-Bossini AJ; de Alba IG; Ortiz-González-Serna R; Serrano-Ortiz Á; Fernández-Martínez NF; Ruiz-Montero R; Cervilla JA
    BMC Med; 2022 Feb; 20(1):92. PubMed ID: 35193574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
    Xu E; Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling long COVID: insights from proteomics and considerations for comprehensive understanding.
    Yang C; Shannon CP; Tebbutt SJ
    EBioMedicine; 2024 Mar; 101():105023. PubMed ID: 38377796
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms.
    Mohamed-Hussein AAR; Amin MT; Makhlouf HA; Makhlouf NA; Galal I; Abd-Elaal HK; Abdeltawab D; Kholief KMS; Hashem MK
    Int J Tuberc Lung Dis; 2021 Sep; 25(9):732-737. PubMed ID: 34802495
    [No Abstract]   [Full Text] [Related]  

  • 14. Symptoms and signs of long COVID: A rapid review and meta-analysis.
    Healey Q; Sheikh A; Daines L; Vasileiou E
    J Glob Health; 2022 May; 12():05014. PubMed ID: 35596571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
    Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
    Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, pathophysiology, prediction and health-related quality of life of long COVID: study protocol of the longitudinal multiple cohort CORona Follow Up (CORFU) study.
    Ghossein-Doha C; Wintjens MSJN; Janssen EBNJ; Klein D; Heemskerk SCM; Asselbergs FW; Birnie E; Bonsel GJ; van Bussel BCT; Cals JWL; Ten Cate H; Haagsma J; Hemmen B; van der Horst ICC; Kietselaer BLJH; Klok FA; de Kruif MD; Linschoten M; van Santen S; Vernooy K; Willems LH; Westerborg R; Warle M; van Kuijk SMJ
    BMJ Open; 2022 Nov; 12(11):e065142. PubMed ID: 36446465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome-Authors' reply.
    Marasco G; Maida M; Cremon C; Barbaro MR; Stanghellini V; Barbara G
    Aliment Pharmacol Ther; 2023 Jul; 58(1):128-129. PubMed ID: 37307549
    [No Abstract]   [Full Text] [Related]  

  • 20. Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning.
    Patel MA; Knauer MJ; Nicholson M; Daley M; Van Nynatten LR; Cepinskas G; Fraser DD
    Mol Med; 2023 Feb; 29(1):26. PubMed ID: 36809921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.